The ONLY Stocks You Should Own in This Sector

Large pharmaceutical companies are facing a crisis. The industry spent a record $65 billion on research and development (R&D) in 2009, but approval rates for new drugs have fallen 44% during the past decade and continue to drop. Also in 2009, drugs launched in the previous five years accounted for only 7% of . . . → Read More: The ONLY Stocks You Should Own in This Sector